RBM22
Pre-mRNA-splicing factor RBM22
Also known as: Cwc2, FLJ10290, fSAP47, RBM22_HUMAN, ZC3H16
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NW64
- Gene
- RBM22
- Ensembl
- ENSG00000086589
- Chromosome
- 5
- Canonical length
- 420 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes an RNA binding protein. The encoded protein may play a role in cell division and may be involved in pre-mRNA splicing. Related pseudogenes exist on chromosomes 6, 7, 9, 13, 16, 18, and X. [provided by RefSeq, Mar 2009]
Canonical amino-acid sequenceUniProt
420 residues, UniProt reviewed canonical sequence.
>Q9NW64|RBM22
1 MATSLGSNTY NRQNWEDADF PILCQTCLGE NPYIRMTKEK YGKECKICAR PFTVFRWCPG
61 VRMRFKKTEV CQTCSKLKNV CQTCLLDLEY GLPIQVRDAG LSFKDDMPKS DVNKEYYTQN
121 MEREISNSDG TRPVGMLGKA TSTSDMLLKL ARTTPYYKRN RPHICSFWVK GECKRGEECP
181 YRHEKPTDPD DPLADQNIKD RYYGINDPVA DKLLKRASTM PRLDPPEDKT ITTLYVGGLG
241 DTITETDLRN HFYQFGEIRT ITVVQRQQCA FIQFATRQAA EVAAEKSFNK LIVNGRRLNV
301 KWGRSQAARG KEKEKDGTTD SGIKLEPVPG LPGALPPPPA AEEEASANYF NLPPSGPPAV
361 VNIALPPPPG IAPPPPPGFG PHMFHPMGPP PPFMRAPGPI HYPSQDPQRM GAHAGKHSSPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RBM22 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 61 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 61 nTPM
- thymus: 39 nTPM
- tongue: 32 nTPM
- ovary: 31 nTPM
- tonsil: 30 nTPM
- lymph node: 27 nTPM
Single-cell type
- neutrophils: 127 nCPM
- endometrial luminal cells: 96 nCPM
- endometrial glandular cells: 96 nCPM
- endometrial secretory cells: 92 nCPM
- syncytiotrophoblasts: 91 nCPM
- cytotrophoblasts: 64 nCPM
Immune cell
- neutrophil: 53 nTPM
- eosinophil: 52 nTPM
- non-classical monocyte: 47 nTPM
- NK-cell: 44 nTPM
- MAIT T-cell: 38 nTPM
- memory B-cell: 38 nTPM
Brain region
- white matter: 40 nTPM
- cerebral cortex: 34 nTPM
- cerebellum: 33 nTPM
- medulla oblongata: 32 nTPM
- basal ganglia: 31 nTPM
- spinal cord: 30 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.14
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.16
- DepMap mean gene effect
- -1.7
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to xenobiotic stimulus
- mRNA cis splicing, via spliceosome
- mRNA splicing, via spliceosome
- positive regulation of protein export from nucleus
- positive regulation of protein import into nucleus
- positive regulation of RNA splicing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA recognition motif domain
- Zinc finger, CCCH-type
- Nucleotide-binding alpha-beta plait domain superfamily
- RNA-binding domain superfamily
- Zinc finger, CCCH-type superfamily
- RNA recognition motif
- Pre-mRNA-splicing factor Cwc2/Slt11
- STL11/RBM22-like, N-terminal domain
- RBM22, CCCH zinc finger domain
- STL11, N-terminal
- RBM22 CCCH zinc finger domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RBM22 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RBM22 as an antibody target. Whether an autoantibody or antibody against RBM22 could matter depends on whether native RBM22 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RBM22 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RBM22 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...